Genetic variation in GLP1R signaling efficiency, GIPR receptor density, and metabolism-related genes (such as FTO and MC4R variants) may influence how strongly a person responds to each medication class
Following 26 weeks of treatment, the mean percent decrease observed in total cholesterol ranged from 2.1 to 8.0%, LDL cholesterol decreased from 3.7 to 14.3%, VLDL decreased from 7.1 to 16.4%, and triglyceride concentrations decreased by 8.4 to 16.6%
A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer
Celiac-superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycemia
Ejaculation latency: 10 mg/kg paroxetine combined with 7.5 mg/kg Atlas987 significantly increased the ejaculation latency compared with 10 mg/kg paroxetine combined with 0 mg/kg Atlas987 ( p = 0.0137)